Nabumetone
Product Images NDC 53002-6960

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 53002-6960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
The text describes a chart showing the plasma concentrations of Nabumetone active metabolite (BMNA) at steady state following once-daily dosing of Nabumetone 1000mg (n=31) and 2000mg (n=12). The chart displays the concentrations over a period of time in hours, with dosages of 1000mg and 2000mg taken daily.*
FDA Label Image

Label Image (Lbl530026960)

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.